Keerthi B Y, Saritha K, Shah Chirali, Thomas Vimala, Cheryala Vikram
Department of General Medicine, Telangana Institute of Medical Sciences and Research, Gachibowli, Hyderabad, India, 500032.
Department of Family Medicine, Telangana Institute of Medical Sciences and Research, Gachibowli, Hyderabad, India, 500032.
Bioinformation. 2022 Apr 30;18(4):402-410. doi: 10.6026/97320630018402. eCollection 2022.
It is of interest to assess the immediate and antecedent causes of mortality amongst adult COVID-19 infected patients with or without comorbidities admitted in an exclusive COVID-19 hospital was conducted the between August 2020 to May 2021. The immediate and antecedent causes were collected from the medical certificate of cause of death (MCCD). Remaining data was extracted from the hospital's record. ICMR protocol was used to grade severity of illness at admission into mild, moderate and severe categories. Clinical status during hospitalisation and most recent radiographic and laboratory data were used to assess disease progression and outcome. This study includes data from 571 people, who died at our centre between August 2020 and May 2021. Patients registered without any co-morbidity were 146 with mean age of 57.53 years; (33/146) were females and (110/46) males. Hypertension (274, 47.99%) was found in a moderately large number of patients followed by diabetes (225, 39.4%) and anaemia (199, 34.6%). Increase in risk of mortality of COVID-19 was found maximum in patients with acute respiratory distress syndrome (72.33%), followed by secondary infections (6.83%). Mortality recorded in this study was mainly in males of older age (50 years and above) with at least one co-morbidity. Anaemia was also prevalent amongst these patients and considered as an independent factor for mortality. Hence, recording of comorbidities and haemoglobin levels may help as a guideline to develop risk stratification and management of patients with COVID-19 to reduce overall mortality.
对2020年8月至2021年5月期间入住一家专门的新冠肺炎医院的成年新冠肺炎感染患者(无论有无合并症)的直接和先前死亡原因进行评估很有意义。直接和先前原因从死亡医学证明书(MCCD)中收集。其余数据从医院记录中提取。采用印度医学研究理事会(ICMR)方案将入院时的疾病严重程度分为轻度、中度和重度。住院期间的临床状况以及最新的影像学和实验室数据用于评估疾病进展和结局。本研究纳入了2020年8月至2021年5月期间在我们中心死亡的571人的数据。登记无任何合并症的患者有146人,平均年龄为57.53岁;女性33人(/146),男性110人(/46)。发现相当多的患者患有高血压(274例,47.99%),其次是糖尿病(225例,39.4%)和贫血(199例,34.6%)。新冠肺炎死亡风险增加在急性呼吸窘迫综合征患者中最高(72.33%),其次是继发感染(6.83%)。本研究记录的死亡主要发生在年龄较大(50岁及以上)且至少有一种合并症的男性中。贫血在这些患者中也很普遍,并被视为死亡的独立因素。因此,记录合并症和血红蛋白水平可能有助于作为制定新冠肺炎患者风险分层和管理的指南,以降低总体死亡率。